Zusammenfassung
Bei einem 45-jährigen Patienten war es nach lateraler Parotidektomie zu einer auf chirurgische Interventionen und Botulinumtoxin therapierefraktären Speichelfistel gekommen. Er wurde in unserer Klinik im Bereich der Restanteile der Gl. parotis einschließlich der Fistelöffnung fraktioniert bestrahlt (Gesamtdosis 30 Gy). Die Sekretion aus der Fistel sistierte im Verlauf vollständig. Auch wenn seit dem Einsatz von Botulinumtoxin die Indikation zur Strahlentherapie nur noch selten gegeben ist, kann die Radiatio als Therapieoption bei therapierefraktären Verläufen daher weiterhin in Betracht gezogen werden.
Abstract
A 45-year-old patient presented with refractory salivary fistula, attributed to multiple surgery and Botulinum toxin, following lateral parotidectomy. He underwent fractionated radiotherapy of the remaining parotid gland including the fistula opening (total dose of 30 Gy) at our clinic. In time, fistula secretion could be inhibited completely. Although the indication for radiotherapy for such fistulas is rare since Botulinum toxin has been in use, it should still be considered in refractory disease courses.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Borg M, Hirst F (1998) The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys 41:1113–1119
Ellies M, Gottstein U, Rohrbach-Volland S et al (2004) Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114:1856–1860
Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122
Kölbl O, Barthel T, Krödel A, Seegenschmiedt MH (2003) Prävention von heterotopen Ossifikationen nach Totalendoprothese des Hüftgelenks. Dtsch Ärztebl 100:2944–2954
Laskawi R, Schott T, Mirzaie-Petri M, Schröder M (1996) Surgical management of pleomorphic adenomas of the parotid gland: a follow-up study of three methods. J Oral Maxillofac Surg 54:1176–1179
Laskawi R, Schott T, Schröder M (1998) Recurrent pleomorphic adenoma of the parotid gland: clinical evaluation and long-term follow up. Br J Oral Maxillofac Surg 36:48–51
Lim YC, Choi EC (2008) Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment. Eur Arch Otorhinolaryngol 265:243–245
Marchese-Ragona R, De Fillipis G, Maroni G, Staffieri A (2005) Treatment of complications of parotid gland surgery. Acta Otorhinolaryngol Ital 25:174–178
Mohammed F, Asaria J, Payne RJ, Freeman JL (2008) Retrospective review of 242 consecutive patients treated surgically for parotid gland tumours. J Otolaryngol Head Neck Surg 37:340–346
Parsons JT (1994) The effects of radiation on normal tissues of the head and neck. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer, a multidisciplinary approach. J.B. Lippincott, Philadelphia/PA, USA, pp 245–290
Robinson AC, Khoury GG, Robinson PM (1989) Role of irradiation in the suppression of parotid secretions. J Laryngol Otol 103:594–595
Shimm DS, Berk FK, Tilsner TJ, Coulthard SW (1992) Low-dose radiation therapy for benign salivary disorders. Am J Clin Oncol 15:76–78
Surenkok S, Dirican B, Beyzadeoglu M, Oysul K (2006) Heel spur radiotherapy and radiation carcinogenesis risk estimation. Radiat Med 24:573–576
Wendt TG (2002) Strahlentherapie im Alter. Onkologie 8:128–133
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Christiansen, H., Wolff, H., Knauth, J. et al. Radiatio. HNO 57, 1325–1328 (2009). https://doi.org/10.1007/s00106-009-1988-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-009-1988-y